Skip to main content
. 2016 Jun 28;60:10.3402/fnr.v60.31288. doi: 10.3402/fnr.v60.31288

Fig. 1.

Fig. 1

Identification of apigenin as an inhibitor of 26S proteasome in HEK293A-luciferase-cODC cells. (a) Chemical structure of apigenin. (b) HEK293A-luciferase-cODC cells were seeded in 96-well plates and treated in the presence of indicated concentrations of apigenin or bortezomib for 3 h. (c) Concentration–response curve for apigenin. The calculated EC50 value was 4.08 µM. (d) HEK293A-luciferase-cODC cells were seeded in 96-well plates and treated with 10 µM apigenin for the indicated time, or treated with 1 µM MG132 for 4 h. Results are representative of three separate experiments. The error bars represent the standard deviation of the measurements. (*) p<0.05, (**) p<0.01, (***) p<0.001 compared to the DMSO control.